No Data
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
12 Health Care Stocks Moving In Thursday's Pre-Market Session
What's Going On With Conduit Pharmaceuticals Shares Today?
Conduit Pharmaceuticals Secures Composition Patent for AZD1656 in Japan, Advancing Intellectual Property Strategy
Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced That the Japan Patent Office Granted a Composition of Matter Patent for Its Lead Asset, AZD1656.
Express News | Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced That the Japan Patent Office Granted a Composition of Matter Patent for Its Lead Asset, AZD1656
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Teddy123 OP : Let's go 0.2 again do it do it